Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis
- PMID: 38700889
Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis
Abstract
The objective of this study was to investigate the risk factors and diagnosis measure of COVID-19-associated pulmonary aspergillosis (CAPA). This study included 201 COVID-19 patients from December 1, 2022, to January 31, 2023; 7 (3.5%) were diagnosed with CAPA. The main risk factors were age, MV, ICU admission and COPD, and the presence of comorbidities such as ARDS and hypoproteinemia in COVID-19 patients, more susceptible to Aspergillus infection. In addition to specimen culture in the lower respiratory tract, the 1,3-β-D-glucan antigen test can serve as an important screening indicator for early CAPA diagnosis in non-granulocytopenia patients.
Keywords: CAPA; COVID-19; diagnosis; infections; risk factors.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
